Evidence map›Paper›PMID 36265519›Full record

ArticleEpidemiology and health2022

The clinical meaning of the area under a receiver operating characteristic curve for the evaluation of the performance of disease markers.

Stefano Parodi, Damiano Verda, Francesca Bagnasco, Marco Muselli

Abstract read
In one paragraph

Article in Epidemiology and health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Potential ecological suitability ofFrontiers in plant science · 2026
    Article
  6. Projected shifts in the potential distribution ofFrontiers in plant science · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Prediction of potential habitat ofFrontiers in plant science · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Current and future distribution ofFrontiers in plant science · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Stefano ParodiScientific Directorate, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Damiano VerdaRulex Innovation Labs, Genoa, Italy.
Francesca BagnascoScientific Directorate, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Marco MuselliRulex Innovation Labs, Genoa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe area under a receiver operating characteristic (ROC) curve (AUC) is a popular measure of pure diagnostic accuracy that is independent from the proportion of diseased subjects in the analysed sample. However, its actual usefulness in the clinical context has been questioned, because it does not seem to be directly related to the actual performance of a diagnostic marker in identifying diseased and non-diseased subjects in real clinical settings. This study evaluates the relationship between the AUC and the proportion of correct classifications (global diagnostic accuracy, GDA) in relation to the shape of the corresponding ROC curves.

methodsWe demonstrate that AUC represents an upward-biased measure of GDA at an optimal accuracy cut-off for balanced groups. The magnitude of bias depends on the shape of the ROC plot and on the proportion of diseased and non-diseased subjects. In proper curves, the bias is independent from the diseased/non-diseased ratio and can be easily estimated and removed. Moreover, a comparison between 2 partial AUCs can be replaced by a more powerful test for the corresponding whole AUCs.

resultsApplications to 3 real datasets are provided: a marker for a hormone deficit in children, 2 tumour markers for malignant mesothelioma, and 2 gene expression profiles in ovarian cancer patients.

conclusionsThe AUC is a measure of accuracy with potential clinical relevance for the evaluation of disease markers. The clinical meaning of ROC parameters should always be evaluated with an analysis of the shape of the corresponding ROC curve.

Indexed as

ROC CurveArea Under CurveBiasChildHumansBinormal modelBiomarkersDiagnostic accuracyMetz and Kronman testReceiver operating characteristic curve

Identifiers

PMID36265519
PMCPMC10089712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.